Advanced search
Publication Cover
HIV Clinical Trials Volume 10, 2009 - Issue 2
Submit an article Journal homepage
84
Views
15
CrossRef citations to date
0
Altmetric
Brief reports

Determinants of Participation in HIV Clinical Trials: The Importance of Patients’ Trust in Their Provider

Elizabeth R. VolkmannCenter for Clinical AIDS Research and Education University of California, Los Angeles, California, USACorrespondence[email protected]
,
Deon ClaiborneCenter for Clinical AIDS Research and Education University of California, Los Angeles, California, USA
&
Judith S. CurrierCenter for Clinical AIDS Research and Education University of California, Los Angeles, California, USA
Pages 104-109 | Published online: 06 Jan 2015

REFERENCES

  • Sung NS, Crowley WF, Gene! M, etal. Central challenges facing the national clinical research enterprise. JAMA. 2003;289:1278–1287.
  • Gifford AL, Cunningham WE, Heslin KC, et al. Participation in research and access to experimental treatment by HIV infected patients. New Engl J Med. 2002;346:1373–1382.
  • Stone VE, Mauch MY, Steger KA. Provider attitudes regarding participation of women and persons of color in AIDS clinical trials. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:245–253.
  • Joseph RR. Viewpoints and concerns of a clinical trial participant. Cancer. 1994;74:2692–2693.
  • Stone VE, Mauch MY, Seger K, et al. Race, gender, drug use, and participation in AIDS clinical trials. Lessons from a municipal hospital cohort. J Gen Intern Med. 1997;12:150–157.
  • Ling J, Rees E, Hardy J. What influences participation in clinical trials in palliative care in a cancer centre? Eur J Cancer. 2000;36:621–626.
  • Fallowfield LJ, Jenkins V, Brennan C, et al. Attitudes of patients to randomized clinical trials of cancer therapy. Eur J Cancer. 1998;34:1554–1559.
  • Ellis PM, Butow PN. Focus group interviews examin-ing attitudes to randomised trials among breast cancer patients and the general community. Aust N Z J Public Health. 1998;22:528–531.
  • Ellis PM, Dowsett SM, Butow PN, Tattersall MH. Attitudes to randomized clinical trials amongst outpatients attending a medical oncology clinic. Health Expect.1999;2:33–43.
  • Freedberg KA, Sullivan L, Georgakis A, et al. Improving participation in HIV clinical trials: impact of a brief interven-tion. HIV Clin Trials. 2001;2: 205–212.
  • Llewellyn-Thomas HA, Thiel EC, Sem FW, Woermke DE. Presenting clinical trial information: a comparison of meth-ods. Patient Educ Counseling. 1995;25:97–107.
  • Westreich L, Levine S, Ginsburg P, Wilets I. Patient knowl-edge about electroconvulsive therapy: effect of an infor-mational video. Convulsive Ther. 1995;11:32–37.
  • Ives NJ, Troop M, Waters A, et al. Does an HIV clinical trial information booklet improve patient knowledge and under-standing of HIV clinical trials? HIV Med. 2001;2:241–249.
  • Priddy FH, Cheng AC, Salazar LF, Frew PM. Racial and ethnic differences in knowledge and willingness to par-ticipate in HIV vaccine trials in an urban population in Southeastern US. Int J STD AIDS. 2006;17:99–102.
  • Degner LF, Kristjanson LJ, Bowman D, et al. Information needs and decisional preferences in women with breast cancer. JAMA. 1997;277:1485–1492.
  • Ellis PM, Butow PN, Tattersall MH, Dunn SM, Houssami N. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate. J Clin Oncol. 200119: 3554–3561.
  • Schneider J, Kaplan SH, Greenfield S, Li W, Wilson IB. Better physician-patient relationships are associated with higher reported adherence to antiretroviral therapy in patients with HIV infection. J Gen Intern Med. 2004;19:1096–1103.
  • Garber M, Hanusa BH, Switzer GE, et al. HIV-infected African Americans are willing to participate in HIV treat-ment trials. J Gen Intern Med. 2007;22:17–42.
  • Wendler D, Kington R, Madans J, etal. Are racial and eth-nic minorities less willing to participate in health research? PLoS Med. 2006;3:e19.
  • Madge S, Mocroft A, Wilson D, et al. Participation in clinical studies among patients infected with HIV-1 in a single treatment centre over 12 years. HIV Med. 2000;1:212–218.
  • Kiwanuka N, Robb M, Kigozi G, et al. Knowledge about vaccines and willingness to participate in preventa-tive HIV vaccine trials. J Acquir Immune Defic Syndr. 2004;36:721–725.
  • Cassileth BR, Lusk EJ, Miller DS, Hurwitz S. Attitudes toward clinical trials among patients and the public. JAMA. 1982;248:968–970.
  • Halpern SD, Metzger DS, Berlin JA, Ubel PA. Who will enroll? Predicting participation in a phase ll AIDS vaccine trial. J Acquir Immune Defic Syndr. 200127: 281–288.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.